Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 8-K (Current Report)
Report Date: July 23, 1997
Reporting Period: Second Quarter and First Six Months ended June 30, 1997
This filing includes an earnings press release and consolidated financial statements. The company reported record quarterly net income, driven by volume growth in Chemicals and Specialties and strong performance in Petroleum downstream operations. All per-share data reflect a 2-for-1 stock split effective May 15, 1997.
Key Financial Metrics
| Metric | Q2 1997 | Q2 1996 | YTD 1997 | YTD 1996 |
|---|---|---|---|---|
| Sales | $11.4 billion | $11.1 billion | $22.6 billion | $21.9 billion |
| Net Income | $1.14 billion | $1.00 billion | $2.16 billion | $1.88 billion |
| Earnings Per Share | $1.01 | $0.89 | $1.91 | $1.68 |
| Dividends Per Share | $0.315 | $0.285 | $0.60 | $0.545 |
| Earnings Before Tax | $1.83 billion | $1.69 billion | $3.63 billion | $3.16 billion |
Segment Performance (Q2 1997 After-Tax Operating Income):
- Petroleum: $246 million (Record quarter; downstream earnings up 105%).
- Polymers: $259 million (Up 6% vs. prior year).
- Fibers: $245 million (Up 18% vs. prior year).
- Life Sciences: $244 million (Slightly lower than prior year).
- Chemicals: $137 million (Down 17% vs. prior year).
- Diversified Businesses: $84 million (Up 65% vs. prior year).
Material Changes vs. Prior Period
- Revenue Growth: Q2 sales increased 2% year-over-year. Chemicals and Specialties sales rose 6% due to 10% volume growth, partially offset by a 4% decline in average selling prices (largely due to a stronger dollar).
- Profitability: Net income increased 14% year-over-year. Adjusted for a nonrecurring charge in Q2 1996, net income and EPS grew 10%.
- Petroleum Segment: Sales declined 2% due to lower crude oil prices ($17.78/barrel, down 7%) and reduced production. However, earnings rose 13% due to significantly higher downstream refined product margins.
- Chemicals Segment: Earnings declined 17% primarily due to lower earnings from white pigments, despite a 10% increase in sales volume.
- Life Sciences: Reported earnings were slightly lower than 1996, but excluding a higher allocation of joint venture income in 1996, underlying agricultural and pharmaceutical earnings rose approximately 20%.
Guidance, Outlook, and Risks
Management Commentary: CEO John A. Krol stated the company is on track for a fourth consecutive year of record earnings. Total shareholder return for the first half of 1997 was 36%, exceeding industry averages.
Strategic Initiatives:
- Acquisition of ICI's white pigments and polyester businesses.
- Acquisition of South Texas gas producing properties.
- Focus on growing businesses with low-cost and technological advantages.
Risks and Contingencies:
- Currency Impact: A stronger dollar negatively impacted selling prices outside the United States.
- Commodity Prices: Crude oil prices averaged 7% lower than the prior year, impacting upstream earnings.
- Operational Issues: Scheduled maintenance at the Humber refinery in the UK affected results outside the U.S. A recall of "Benlate" 50 DF fungicide resulted in a $63 million charge.
- Restructuring: Employee separation costs were incurred in the Chemicals and Fibers segments.
Investor Verification Checklist
- Verify the impact of the 2-for-1 stock split on historical per-share comparisons.
- Confirm the sustainability of downstream petroleum margins given the decline in crude oil prices.
- Assess the integration progress and financial impact of the pending ICI acquisition.
- Review the specific volume drivers in the Chemicals and Specialties segments to ensure growth is not solely price-driven.
- Monitor the resolution of the "Benlate" fungicide recall and associated environmental or legal contingencies.